Vyome Holdings, Inc.
HIND
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.48M
Close$
$2.07
5.2% downside
Current Fair Value
5.2% downsideOvervalued by 5.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.48 Million |
|---|---|
| Enterprise Value | $7.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.75 |
| Beta | 1.49 |
| Outstanding Shares | 7,018,528 |
Return
| Return on Equity | -161.66% |
|---|---|
| Return on Assets | -106.56% |
| Return on Invested Capital | -134.48% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0.1 |
| Price to Sales | -2.18 |
| Price to Book Ratio | 2.18 |
| Enterprise Value to Revenue | -3.86 |
| Enterprise Value to EBIT | -0.78 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
$26,955
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$24,111
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.97%▲ 0.41% |
|---|---|
| Total Invested | $296,510▲ 49.55% |
| Investors Holding | 12▲ 3.00% |
ESG Score
No data
About Vyome Holdings, Inc.
18 employees
CEO: Venkateswarlu Nelabhotla Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disor...